Výsledky vyhledávání

Akademický článek

Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis.

Autor: Lee SF; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore leesf@nuhs.edu.sg.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Kennedy SKF; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada., Caini S; Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPO), Florence, Italy., Wong HCY; Department of Oncology, Princess Margaret Hospital, Hospital Authority, Hong Kong., Yip PL; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong., Poortmans PM; Department of Radiation Oncology, Iridium Netwerk, Wilrijk-Antwerp, Belgium.; Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk-Antwerp, Belgium., Meattini I; Department of Experimental and Clinical Biomedical Sciences 'M Serio', University of Florence, Florence, Italy.; Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy., Kaidar-Person O; Breast Cancer Radiation Therapy Unit, Sheba Medical Center, Ramat Gan, Israel.; School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; GROW-School for Oncology and Reproductive (Maastro), Maastricht University, Maastricht, Netherlands., Recht A; Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA., Hijal T; Division of Radiation Oncology, McGill University Health Centre, Montreal, QC, Canada., Torres MA; Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA., Cao JQ; Section of Radiation Oncology, Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Corbin KS; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Choi JI; Department of Radiation Oncology, New York Proton Center and Memorial Sloan Kettering Cancer Center, New York, NY, USA., Koh WY; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Kwan JYY; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada., Karam I; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada., Chan AW; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada., Chow E; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada., Marta GN; Department of Radiation Oncology, Hospital Sírio-Libanês, São Paulo, Brazil.; Latin America Cooperative Oncology Group, Porto Alegre, Brazil.; Postgraduate Program, Department of Radiology and Oncology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Publikováno v: BMJ (Clinical research ed.) [BMJ] 2024 Sep 11; Vol. 386, pp. e079089. Date of Electronic Publication: 2024 Sep 11.

Zobrazit plný text záznamu

Akademický článek

Protocol for a systematic review with prospective individual patient data meta-analysis in EGFR-mutant NSCLC with brain metastases to assess the effect of SRS+osimertinib compared to osimertinib alone: the STARLET Collaboration.

Autor: Robledo KP; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, New South Wales, Australia kristy.robledo@sydney.edu.au., Lefresne S; BC Cancer Agency, Vancouver, British Columbia, Canada.; The University of British Columbia, Vancouver, British Columbia, Canada., Soon YY; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, New South Wales, Australia.; National University Cancer Institute, Singapore.; National University Health System, Singapore., Sahgal A; Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Pinkham MB; Radiation Oncology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Nichol A; BC Cancer Agency, Vancouver, British Columbia, Canada., Soo RA; National University Cancer Institute, Singapore.; National University Health System, Singapore., Parmar A; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Hegi-Johnson F; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Doherty M; St Vincent's University Hospital, Dublin, Dublin, Ireland., Solomon BJ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Shultz DB; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Tham IW; Mount Elizabeth Hospital, Singapore., Sacher AG; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Tey J; National University Cancer Institute, Singapore.; National University Health System, Singapore., Leong CN; National University Cancer Institute, Singapore.; National University Health System, Singapore., Koh WY; National University Cancer Institute, Singapore.; National University Health System, Singapore., Huang Y; National University Cancer Institute, Singapore.; National University Health System, Singapore., Ang YLE; National University Cancer Institute, Singapore.; National University Health System, Singapore., Low J; National University Cancer Institute, Singapore.; National University Health System, Singapore., Yong C; National University Health System, Singapore.; National University Hospital, Singapore., Lim MC; National University Health System, Singapore.; National University Hospital, Singapore., Tan AP; National University Health System, Singapore.; National University Hospital, Singapore., Lee CK; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, New South Wales, Australia., Ho C; BC Cancer Agency, Vancouver, British Columbia, Canada.; The University of British Columbia, Vancouver, British Columbia, Canada.

Publikováno v: BMJ open [BMJ Open] 2024 Jul 05; Vol. 14 (7), pp. e078335. Date of Electronic Publication: 2024 Jul 05.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání